According to Affimed 's latest financial reports and stock price the company's current number of shares outstanding is 14,933,933. At the end of 2023 the company had 14,933,933 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 14.93 M | 0% |
2022 | 14.93 M | 24.67% |
2021 | 11.97 M | 39.24% |
2020 | 8.6 M | 37.77% |
2019 | 6.24 M | 0.07% |
2018 | 6.24 M | 36.05% |
2017 | 4.58 M | 35.34% |
2016 | 3.38 M | 2.54% |
2015 | 3.3 M | 37.18% |
2014 | 2.4 M | 0.45% |
2013 | 2.39 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Repligen
RGEN | 55,815,666 | 273.75% | ๐บ๐ธ USA |
Merrimack Pharmaceuticals MACK | 14,321,000 | -4.10% | ๐บ๐ธ USA |
Agenus
AGEN | 378,152,000 | 2,432.17% | ๐บ๐ธ USA |
Acorda Therapeutics
ACOR | 1,242,000 | -91.68% | ๐บ๐ธ USA |